Discontinuation report BUSULFEX

Last updated on 2020-09-02 History
Report ID 120940
Drug Identification Number 02240602
Brand name BUSULFEX
Common or Proper name busulfex
Company Name OTSUKA PHARMACEUTICAL CO LTD
Market Status CANCELLED POST MARKET
Active Ingredient(s) BUSULFAN
Strength(s) 60MG
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 6mg/mL, 10 mL vial
ATC code L01AB
ATC description ALKYLATINGAGENTS
Reason for discontinuation Business reasons
Anticipated discontinuation date 2020-09-01
Actual discontinuation date 2020-09-01
Remaining supply date 2020-10-01
Discontinuation status Discontinued
Discontinuation decision reversal No
Information on remaining supply
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 2-9 KANDA-TSUKASAMACHI
CHIYODA-KU TOKYO, --
JAPAN 101-8535
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v6 2020-09-02 English Compare
v5 2020-07-23 French Compare
v4 2020-07-23 English Compare
v3 2020-07-23 French Compare
v2 2020-07-23 English Compare
v1 2020-07-23 English Compare

Showing 1 to 6 of 6